Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment

被引:75
作者
Caselli, Richard J. [1 ,6 ]
Chen, Kewei [2 ,3 ,5 ,6 ]
Lee, Wendy [2 ,3 ,5 ,6 ]
Alexander, Gene E. [4 ,6 ,7 ]
Reiman, Eric M. [2 ,3 ,5 ,6 ]
机构
[1] Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA
[2] Mayo Clin, Dept Psychiat, Scottsdale, AZ 85259 USA
[3] Banner Alzheimers Inst, Phoenix, AZ USA
[4] Mayo Clin, Dept Psychol, Scottsdale, AZ 85259 USA
[5] Banner Good Samaritan Med Ctr, Phoenix, AZ USA
[6] Arizona Alzheimers Res Consortium, Phoenix, AZ USA
[7] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA
关键词
D O I
10.1001/archneurol.2008.1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Before symptomatic memory loss, healthy apolipoprotein E epsilon 4 (APOE epsilon 4) (OMIM 104310) carriers demonstrate accelerated longitudinal decline on memory tests, suggesting the existence of a transitional state between normal aging and mild cognitive impairment (MCI), which we have called amnestic pre-MCI. Objective: To support our neuropsychological construct of pre-MCI by characterizing and comparing the relationship between measurements of baseline regional hypometabolism and subsequent rates of memory decline in a group of individuals with neuropsychologically defined asymptomatic memory decline (pre-MCI group) and in nondecliners after controlling for APOE epsilon 4 gene dose. Design: Longitudinal study. Setting: Academic medical center. Participants: Of 139 healthy individuals in the Arizona APOE Cohort aged 50 to 69 years who underwent longitudinal neuropsychological testing and fludeoxyglucose F 18-positron emission tomography (FDG-PET) since 1994, 10 met our criteria for amnestic pre-MCI, and 15 showed no decline. Main Outcome Measures: Correlations between lower regional cerebral metabolic rates for glucose (CMRgl) and rates of verbal memory test decline that occurred at a mean of 41 months after baseline FDG-PET using an automated brain mapping algorithm (SPM5). Results: The pre-MCI and nondecliner groups did not differ in mean (SD) age (56.8 [4.8] years), education (16.5 [2.3] years), sex (19 women [76%]), or APOE epsilon 4 carrier status (12 epsilon 4 carriers [48%)]. After controlling for APOE e4 gene dose, the pre-MCI group had significant correlations between lower baseline CMRgl in the posterior cingulate, bilateral parietal, and left prefrontal regions (known to be preferentially affected by Alzheimer disease) and subsequent verbal memory decline. Nondecliners had significant correlations bilaterally in the posterior and midcingulate cortices. Correlations in the left parietal, left temporal, and bilateral frontal regions were significantly greater in the pre-MCI group than those in the nondecliner group. Conclusion: Individuals with amnestic pre-MCI showed significantly greater correlations between cerebral hypometabolism and subsequent long-term memory decline than nondecliners in Alzheimer disease-affected brain regions.
引用
收藏
页码:1231 / 1236
页数:6
相关论文
共 34 条
[1]   Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer's disease treatment studies [J].
Alexander, GE ;
Chen, K ;
Pietrini, P ;
Rapoport, SI ;
Reiman, EM .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (05) :738-745
[2]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[3]  
Caselli R J, 2004, Neurology, V62, P1990
[4]   Cognitive domain decline in healthy apolipoprotein E ε4 Homozygotes before the diagnosis of mild cognitive impairment [J].
Caselli, Richard J. ;
Reiman, Eric M. ;
Locke, Dona E. C. ;
Hutton, Michael L. ;
Hentz, Joseph G. ;
Hoffman-Snyder, Charlene ;
Woodruff, Bryan K. ;
Alexander, Gene E. ;
Osborne, David .
ARCHIVES OF NEUROLOGY, 2007, 64 (09) :1306-1311
[5]   Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function [J].
Chen, K ;
Bandy, D ;
Reiman, E ;
Huang, SC ;
Lawson, M ;
Feng, D ;
Yun, LS ;
Palant, A .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (07) :716-723
[6]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[7]   Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease [J].
de Leon, M. J. ;
Mosconi, L. ;
Blennow, K. ;
DeSanti, S. ;
Zinkowski, R. ;
Mehta, P. D. ;
Pratico, D. ;
Tsui, W. ;
Saint Louis, L. A. ;
Sobanska, L. ;
Brys, M. ;
Li, Y. ;
Rich, K. ;
Rinne, J. ;
Rusinek, H. .
IMAGING AND THE AGING BRAIN, 2007, 1097 :114-145
[8]   High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes [J].
Ghebremedhin, E ;
Schultz, C ;
Braak, E ;
Braak, H .
EXPERIMENTAL NEUROLOGY, 1998, 153 (01) :152-155
[9]  
HIXSON JE, 1990, J LIPID RES, V31, P545
[10]   Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia [J].
Jicha, Gregory A. ;
Parisi, Joseph E. ;
Dickson, Dennis W. ;
Johnson, Kris ;
Cha, Ruth ;
Ivnik, Robert J. ;
Tangalos, Eric G. ;
Boeve, Bradley F. ;
Knopman, David S. ;
Braak, Heiko ;
Petersen, Ronald C. .
ARCHIVES OF NEUROLOGY, 2006, 63 (05) :674-681